An autopsy study describing causes of death and comparing clinico-pathological findings among hospitalized patients in kampala, uganda

listen audio

Study Justification:
– Autopsy is the gold standard for determining the cause of death, especially in settings with limited access to diagnostic testing during life.
– Information on causes of death in HIV-infected patients in Sub-Saharan Africa is mainly derived from observational cohort and verbal autopsy studies, but autopsy examination provides more accurate and detailed information.
– The study aimed to describe and compare the clinical and autopsy causes of death and contributory findings in hospitalized HIV-infected and HIV-uninfected patients in Uganda.
Study Highlights:
– Autopsies were performed on patients who died on a combined infectious diseases gastroenterology ward in Mulago Hospital in Kampala, Uganda.
– Fifty-three complete autopsies were performed, with 66% of patients being HIV-positive, 21% HIV-negative, and 13% with an unknown HIV serological status.
– Infectious diseases caused death in 83% of HIV-positive patients, with disseminated TB as the main diagnosis causing 37% of deaths.
– The spectrum of illness and causes of death were substantially different between HIV-positive and HIV-negative patients.
– Autopsy examination remains an important tool to ascertain causes of death, particularly in settings with limited access to diagnostic testing during life.
– HIV-positive patients continue to die from treatable and clinically undiagnosed infectious diseases.
Recommendations for Lay Reader and Policy Maker:
– Further investigation into empiric treatment for common infections in HIV-positive patients until rapid-point of care testing is available to confirm these infections.
– Increased access to diagnostic testing during life to improve accuracy in diagnosing and treating infectious diseases in HIV-positive patients.
Key Role Players:
– Clinical doctors and pathologists for conducting autopsies and analyzing the findings.
– Next of kin of deceased patients for providing consent and clinical information.
– Translators, if needed, to assist with providing information in the local language.
Cost Items for Planning Recommendations:
– Budget items to consider for planning the recommendations include:
– Training and capacity building for healthcare professionals on rapid-point of care testing.
– Procurement and maintenance of diagnostic testing equipment.
– Development and implementation of guidelines for empiric treatment.
– Communication and education materials for patients and healthcare professionals.
– Monitoring and evaluation of the implementation of recommendations.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong because it is based on a complete autopsy study conducted on hospitalized patients in Uganda. The study includes a large sample size and provides detailed information on the causes of death and contributing findings. However, to improve the evidence, the abstract could include information on the methodology used for data analysis and statistical significance of the findings.

Background: Information on causes of death in HIV-infected patients in Sub-Saharan Africa is mainly derived from observational cohort and verbal autopsy studies. Autopsy is the gold standard to ascertain cause of death. We conducted an autopsy study to describe and compare the clinical and autopsy causes of death and contributory findings in hospitalized HIV-infected and HIV-uninfected patients in Uganda. Methods: Between May and September 2009 a complete autopsy was performed on patients that died on a combined infectious diseases gastroenterology ward in Mulago Hospital in Kampala, Uganda. Autopsy cause of death and contributing findings were based on the macro- and microscopic post-mortem findings combined with clinical information. Clinical diagnoses were reported by the ward doctor and classified as confirmed, highly suspected, considered or not considered, based on information derived from the medical chart. Results are reported according to HIV serostatus. Results: Fifty-three complete autopsies were performed in 66% HIV-positive, 21% HIV-negative and 13% patients with an unknown HIV serological status. Infectious diseases caused death in 83% of HIV-positive patients, with disseminated TB as the main diagnosis causing 37% of deaths. The spectrum of illness and causes of death were substantially different between HIV-positive and HIV-negative patients. In HIV-positive patients 12% of postmortem diagnoses were clinically confirmed, 27% highly suspected, 16% considered and 45% not considered. In HIV-negative patients 17% of postmortem diagnoses were clinically highly suspected, 42% considered and 42% not considered. Conclusion: Autopsy examination remains an important tool to ascertain causes of death particularly in settings with limited access to diagnostic testing during life. HIV-positive patients continue to die from treatable and clinically undiagnosed infectious diseases. Until rapid-point of care testing is available to confirm common infections, empiric treatment should be further investigated.

Mulago National Tertiary Referral Hospital is located in Kampala, Uganda and is a university teaching centre. Over the last 10 years, approximately 6800 patients died annually in Mulago Hospital including maternal and child deaths. Based on data from the mortuary, the autopsy rate in Mulago Hospital over the past decade has been stable at 5%. This study was conducted on a combined infectious diseases and gastroenterology ward. The study team included clinical doctors and pathologists. Next of kin of all patients that died on weekdays in the period from May–September 2009 on the study ward were asked for written informed consent to participate in the study. Both verbal and written information about the research and the autopsy procedure was provided in English and Luganda, the main local language. If needed, a translator was asked to assist. Clinical information was collected by interviewing the next of kin using a standardized questionnaire and by reviewing the medical chart of the deceased. After informed consent was obtained, the autopsy was performed within 12 hours. The body was embalmed free of charge afterwards. Patients that died without an available adult relative were excluded from the study. The doctor on the ward was asked for the clinical cause of death and any contributory condition(s). Afterwards the study team reviewed all medical charts to collect diagnostic evidence. Four groups of clinical diagnoses were defined: HIV status was abstracted from the medical chart. For those unaware of their serological status on admission, provider-initiated, free, opt-out HIV testing had been offered according to the hospital guidelines. The algorithm for rapid testing involved 3 sequential HIV tests: Determine TM (Abbot Laboratories by Abbot Japan CO. LTD, Minato-KU, Tokyo, Japan), HIV 1/2 Stat-Pak (Chembio Diagnostics Systems, 3661 Horseblock Road, Med Ford, New York, 11763, USA) and Unigold TM (Trinity Biotech PLC, IDA Business Park, Bray, Cowicklow, Ireland). After informed consent was obtained, a complete autopsy examination was performed, eviscerating all organs including the brain. Standard tissue sections were taken from every organ and from any macroscopically detected lesion. All samples were fixed in 10% formalin solution. Fixed tissue samples were processed for routine hematoxylin and eosin stain (H&E) following standard protocols. The H&E stained slides were examined by light microscopy by three experienced pathologists (R. Lukande, E. Van Marck and A. Nelson). When indicated, special stains for organisms were done including Ziehl-Neelsen (ZN), Grocott-Methenamine Silver, Brown-Hopps Gram, Periodic-Acid Schiff and mucicarmine. Acid fast bacilli seen after ZN staining were classified as mycobacterium tuberculosis, taking into account possible errors due to mycobacterial infections caused by other mycobacteria. When indicated we confirmed the diagnosis of Kaposi’s sarcoma and cytomegalovirus infection by immunohistochemistry using commercially available mouse monoclonal antibodies; LANA1 for HHV8, Cell Marque (reference number 265M-18) and CMV antibody, clone DDG9/CCH2, Ventana (reference number 760-2638). The cause of death and contributing findings were formulated based on the clinical information combined with the macro- and microscopic post-mortem findings. The study received ethical approval from the Makerere University Research and Ethics Committee, the Mulago Internal Review Board and the Infectious Diseases Institute Scientific Review Committee. The study received final approval and registration by the Uganda National Council of Science and Technology (ADM 154/212/01). Data were analyzed using STATA version 11.0 (Stat Corp., College Station, TX, Texas, USA). Data are expressed as mean with a 95% confidence interval (95% CI) or as median with a range.

Based on the provided information, here are some potential innovations that could improve access to maternal health:

1. Telemedicine: Implementing telemedicine services can provide remote access to healthcare professionals for pregnant women, allowing them to receive medical advice, consultations, and monitoring without having to travel long distances to healthcare facilities.

2. Mobile health (mHealth) applications: Developing mobile applications that provide information and resources on maternal health, such as prenatal care guidelines, nutrition advice, and appointment reminders, can help educate and empower pregnant women to take better care of themselves and their babies.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, health education, and referrals to pregnant women in remote or underserved areas can improve access to maternal health services.

4. Maternal health clinics on wheels: Creating mobile clinics equipped with necessary medical equipment and staffed by healthcare professionals can bring essential prenatal care and services directly to communities that lack access to healthcare facilities.

5. Financial incentives: Implementing financial incentives, such as cash transfers or subsidies, for pregnant women to seek prenatal care and deliver at healthcare facilities can encourage them to overcome financial barriers and access necessary maternal health services.

6. Public-private partnerships: Collaborating with private healthcare providers to expand access to maternal health services in underserved areas can help bridge the gap between supply and demand.

7. Maternal health information systems: Establishing robust information systems that track and monitor maternal health indicators can help identify gaps in access and quality of care, enabling policymakers to make informed decisions and allocate resources effectively.

8. Maternal health awareness campaigns: Conducting targeted awareness campaigns to educate communities about the importance of maternal health, the benefits of prenatal care, and the risks of home births can help change attitudes and behaviors, leading to increased access to maternal health services.

It’s important to note that these recommendations are general and may need to be tailored to the specific context and needs of the community in Kampala, Uganda.
AI Innovations Description
The study described in the title and description focuses on conducting autopsies to determine the causes of death among hospitalized patients in Kampala, Uganda. While this study does not directly address improving access to maternal health, it provides valuable information that can be used to develop recommendations for innovation in this area.

Based on the findings of the study, here is a recommendation that can be used to develop an innovation to improve access to maternal health:

1. Implement routine autopsies for maternal deaths: Similar to the autopsies conducted in this study, routine autopsies can be performed for maternal deaths in order to accurately determine the cause of death. This can help identify any underlying medical conditions or complications that may have contributed to the death, and inform strategies for prevention and treatment.

By implementing routine autopsies for maternal deaths, healthcare providers can gain a better understanding of the specific causes and contributing factors, leading to improved care and prevention strategies. This can ultimately help reduce maternal mortality rates and improve access to maternal health services.
AI Innovations Methodology
Based on the provided information, it seems that the request is to consider innovations and recommendations to improve access to maternal health. However, the given description is about an autopsy study conducted in Kampala, Uganda, which may not directly relate to maternal health.

To provide recommendations for improving access to maternal health, it would be helpful to have more specific information about the challenges or issues faced in accessing maternal health services in the given context. Once that information is provided, I can provide targeted recommendations.

Regarding the methodology to simulate the impact of these recommendations on improving access to maternal health, here is a general approach:

1. Define the objectives: Clearly state the goals and objectives of the simulation study. For example, it could be to assess the impact of implementing specific interventions or policies on improving access to maternal health services.

2. Identify key variables: Identify the key variables that are relevant to access to maternal health services. This may include factors such as distance to health facilities, availability of skilled healthcare providers, affordability of services, cultural barriers, etc.

3. Data collection: Gather data on the identified variables. This may involve collecting data from various sources such as surveys, health facility records, demographic data, etc. Ensure that the data collected is reliable and representative of the target population.

4. Model development: Develop a simulation model that represents the system or context under study. This could be a mathematical model, a computer-based simulation, or a combination of both. The model should incorporate the identified variables and their relationships.

5. Parameter estimation: Estimate the parameters of the model using the collected data. This may involve statistical analysis, calibration, or validation of the model.

6. Scenario analysis: Define different scenarios to simulate the impact of various recommendations or interventions. For example, you could simulate the effect of increasing the number of health facilities, improving transportation infrastructure, or implementing community-based health programs.

7. Simulation and analysis: Run the simulation model using the defined scenarios and analyze the results. This may involve measuring the changes in access to maternal health services, such as the number of women able to access antenatal care, skilled birth attendance, or postnatal care.

8. Interpretation and recommendations: Interpret the simulation results and draw conclusions based on the analysis. Use the findings to make recommendations for improving access to maternal health services.

It’s important to note that the specific details of the methodology will depend on the context and available resources. The above steps provide a general framework for conducting a simulation study to assess the impact of recommendations on improving access to maternal health.

Partagez ceci :
Facebook
Twitter
LinkedIn
WhatsApp
Email